Search Page

1

Cite

Share

Epidemiology, risk factors and management of paediatric diabetic retinopathy.

Sultan MB, Starita C, Huang K. Sultan MB, et al. Among authors: starita c. Br J Ophthalmol. 2012 Mar;96(3):312-7. doi: 10.1136/bjophthalmol-2011-300169. Epub 2012 Jan 12. Br J Ophthalmol. 2012. PMID: 22241926 Review.

Cite

Share

2

Cite

Share

Severe Acute Respiratory Syndrome Coronavirus 2: Vaccine Hesitancy Among Underrepresented Racial and Ethnic Groups With HIV in Miami, Florida.

Jones DL, Salazar AS, Rodriguez VJ, Balise RR, Starita CU, Morgan K, Raccamarich PD, Montgomerie E, Nogueira NF, Barreto Ojeda I, Maddalon M, Rodriguez NLY, Brophy T, Martinez T, Alcaide ML. Jones DL, et al. Among authors: starita cu. Open Forum Infect Dis. 2021 Mar 26;8(6):ofab154. doi: 10.1093/ofid/ofab154. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34621912 Free PMC article.

Cite

Share

3

Cite

Share

Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy.

Starita C, Patel M, Katz B, Adamis AP. Starita C, et al. Dev Ophthalmol. 2007;39:122-148. doi: 10.1159/000098504. Dev Ophthalmol. 2007. PMID: 17245083 Review.

Cite

Share

4

Cite

Share

Hematological, Biochemical, and Serological Findings in Healthy Canine Blood Donors after the Administration of CaniLeish® Vaccine.

Starita C, Gavazza A, Lubas G. Starita C, et al. Vet Med Int. 2016;2016:4601893. doi: 10.1155/2016/4601893. Epub 2016 May 22. Vet Med Int. 2016. PMID: 27313949 Free PMC article.

Cite

Share

5

Cite

Share

Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD).

Hussain AA, Starita C, Hodgetts A, Marshall J. Hussain AA, et al. Among authors: starita c. Exp Eye Res. 2010 Jun;90(6):703-10. doi: 10.1016/j.exer.2010.02.013. Epub 2010 Mar 3. Exp Eye Res. 2010. PMID: 20206163

Cite

Share

6

Cite

Share

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.

Boyer DS, Goldbaum M, Leys AM, Starita C; V.I.S.I.O.N. Study Group. Boyer DS, et al. Among authors: starita c. Br J Ophthalmol. 2014 Nov;98(11):1543-6. doi: 10.1136/bjophthalmol-2013-304075. Epub 2014 Jul 4. Br J Ophthalmol. 2014. PMID: 24997182 Clinical Trial.

Cite

Share

7

Cite

Share

Hydrodynamics of ageing Bruch's membrane: implications for macular disease.

Starita C, Hussain AA, Pagliarini S, Marshall J. Starita C, et al. Exp Eye Res. 1996 May;62(5):565-72. doi: 10.1006/exer.1996.0066. Exp Eye Res. 1996. PMID: 8759524

Cite

Share

8

Cite

Share

The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.

Scanlon PH, Loftus J, Starita C, Stratton IM. Scanlon PH, et al. Among authors: starita c. Diabet Med. 2015 Jan;32(1):97-101. doi: 10.1111/dme.12593. Epub 2014 Oct 13. Diabet Med. 2015. PMID: 25251842 Free PMC article.

Cite

Share

9

Cite

Share

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema.

Sivaprasad S, Browning RC, Starita C. Sivaprasad S, et al. Among authors: starita c. Clin Ophthalmol. 2014 Aug 21;8:1565-71. doi: 10.2147/OPTH.S68498. eCollection 2014. Clin Ophthalmol. 2014. PMID: 25187694 Free PMC article.

Cite

Share

10

Cite

Share

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension.

Eveleth D, Starita C, Tressler C. Eveleth D, et al. Among authors: starita c. BMC Ophthalmol. 2012 May 18;12:9. doi: 10.1186/1471-2415-12-9. BMC Ophthalmol. 2012. PMID: 22607109 Free PMC article. Clinical Trial.

Cite

Share